South Korea
# |
Name |
Net Cash Used Provided By Financing Activities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 591.18 M
|
Dec. 31, 2023 | USD 8.02 | 4.65% |
|
South Korea |
|
2 |
USD 107.95 M
|
Dec. 31, 2023 | USD 9.61 | -3.70% |
|
South Korea |
|
3 |
USD 88.54 M
|
Dec. 31, 2023 | USD 0.50 | -4.09% |
|
South Korea |
|
4 |
USD 77.19 M
|
Dec. 31, 2023 | USD 88.80 | -5.65% |
|
South Korea |
|
5 |
USD 63.54 M
|
Dec. 31, 2023 | USD 54.68 | -7.62% |
|
South Korea |
|
6 |
USD 59.01 M
|
Dec. 31, 2023 | USD 3.10 | -3.13% |
|
South Korea |
|
7 |
USD 46.41 M
|
Dec. 31, 2023 | USD 3.04 | -3.81% |
|
South Korea |
|
8 |
USD 44.55 M
|
Dec. 31, 2023 | USD 3.69 | -1.06% |
|
South Korea |
|
9 |
USD 41.92 M
|
Dec. 31, 2023 | USD 33.57 | -2.13% |
|
South Korea |
|
10 |
USD 39.24 M
|
Dec. 31, 2023 | USD 83.97 | -5.00% |
|
South Korea |
|
11 |
USD 33.21 M
|
Dec. 31, 2023 | USD 6.88 | -1.99% |
|
South Korea |
|
12 |
USD 31.43 M
|
Dec. 31, 2023 | USD 1.73 | -2.46% |
|
South Korea |
|
13 |
USD 30.12 M
|
Dec. 31, 2023 | USD 89.76 | -4.42% |
|
South Korea |
|
14 |
USD 24.61 M
|
Dec. 31, 2023 | USD 1.37 | -0.64% |
|
South Korea |
|
15 |
USD 22.13 M
|
Dec. 31, 2023 | USD 5.23 | -2.06% |
|
South Korea |
|
16 |
USD 21.04 M
|
Dec. 31, 2023 | USD 65.38 | -0.04% |
|
South Korea |
|
17 |
USD 20.26 M
|
Dec. 31, 2023 | USD 4.14 | -7.03% |
|
South Korea |
|
18 |
USD 16.20 M
|
Dec. 31, 2023 | USD 1.18 | -3.42% |
|
South Korea |
|
19 |
USD 14.99 M
|
Dec. 31, 2023 | USD 9.80 | -1.72% |
|
South Korea |
|
20 |
USD 12.33 M
|
Dec. 31, 2023 | USD 8.58 | -5.12% |
|
South Korea |
|
21 |
USD 11.25 M
|
Dec. 31, 2023 | USD 1.23 | -3.88% |
|
South Korea |
|
22 |
USD 10.79 M
|
Dec. 31, 2023 | USD 11.53 | -7.22% |
|
South Korea |
|
23 |
USD 9.98 M
|
Dec. 31, 2023 | USD 3.29 | -3.64% |
|
South Korea |
|
24 |
USD 8.54 M
|
Dec. 31, 2023 | USD 17.88 | -1.83% |
|
South Korea |
|
25 |
USD 7.66 M
|
Dec. 31, 2023 | USD 11.62 | -0.90% |
|
South Korea |
|
26 |
USD 6.80 M
|
Dec. 31, 2023 | USD 2.87 | -2.35% |
|
South Korea |
|
27 |
USD 6.26 M
|
Dec. 31, 2023 | USD 8.44 | -2.89% |
|
South Korea |
|
28 |
USD 5.69 M
|
Dec. 31, 2023 | USD 14.37 | -3.79% |
|
South Korea |
|
29 |
USD 5.50 M
|
Dec. 31, 2023 | USD 3.01 | -3.95% |
|
South Korea |
|
30 |
USD 5.09 M
|
Dec. 31, 2023 | USD 70.28 | -5.55% |
|
South Korea |
|
31 |
USD 4.96 M
|
Dec. 31, 2023 | USD 1.12 | -3.94% |
|
South Korea |
|
32 |
USD 4.50 M
|
Dec. 31, 2023 | USD 4.07 | -1.95% |
|
South Korea |
|
33 |
USD 3.68 M
|
Dec. 31, 2023 | USD 7.21 | -0.62% |
|
South Korea |
|
34 |
USD 3.09 M
|
Dec. 31, 2023 | USD 12.66 | -2.66% |
|
South Korea |
|
35 |
USD 2.25 M
|
Dec. 31, 2023 | USD 1.61 | -1.19% |
|
South Korea |
|
36 |
USD 2.00 M
|
Dec. 31, 2023 | USD 3.25 | -3.09% |
|
South Korea |
|
37 |
USD 1.55 M
|
Dec. 31, 2023 | USD 2.33 | -4.21% |
|
South Korea |
|
38 |
USD 1.33 M
|
Dec. 31, 2023 | USD 240.05 | -5.25% |
|
South Korea |
|
39 |
USD 1.10 M
|
Dec. 31, 2023 | USD 25.27 | 1.91% |
|
South Korea |
|
40 |
USD 434.71 K
|
Dec. 31, 2023 | USD 8.83 | 4.03% |
|
South Korea |
|
41 |
USD -44.52 K
|
Dec. 31, 2023 | USD 8.66 | -7.96% |
|
South Korea |
|
42 |
USD -345.21 K
|
Dec. 31, 2023 | USD 9.81 | -0.42% |
|
South Korea |
|
43 |
USD -654.75 K
|
Dec. 31, 2023 | USD 64.97 | -2.50% |
|
South Korea |
|
44 |
USD -1.09 M
|
Dec. 31, 2023 | USD 0.97 | -2.69% |
|
South Korea |
|
45 |
USD -1.49 M
|
Dec. 31, 2023 | USD 11.00 | -3.03% |
|
South Korea |
|
46 |
USD -1.76 M
|
Dec. 31, 2023 | USD 9.85 | -4.50% |
|
South Korea |
|
47 |
USD -1.77 M
|
Dec. 31, 2023 | USD 1.89 | -1.74% |
|
South Korea |
|
48 |
USD -3.17 M
|
Dec. 31, 2023 | USD 31.05 | -1.12% |
|
South Korea |
|
49 |
USD -3.19 M
|
Dec. 31, 2023 | USD 15.36 | -2.10% |
|
South Korea |
|
50 |
USD -3.26 M
|
Dec. 31, 2023 | USD 3.22 | 0.07% |
|
South Korea |
The Healthcare company in South Korea with the highest Net Cash Used Provided By Financing Activities is SD BioSensor, Inc (KSE: 137310.KS) at USD 591.18 M.
The Healthcare company in South Korea with the lowest Net Cash Used Provided By Financing Activities is Samsung Biologics Co.,Ltd. (KSE: 207940.KS) at USD -487.72 M.
The top 10 Healthcare companies in South Korea by Net Cash Used Provided By Financing Activities are SD BioSensor, Inc, Green Cross Holdings Corporation, Aprogen pharmaceuticals,Inc., Green Cross Corporation, ST Pharm Co.,Ltd., Bukwang Pharmaceutical Co., Ltd., Genexine, Inc., Kwang Dong Pharmaceutical Co., Ltd., Dong-A ST Co., Ltd. and Yuhan Corporation.
The bottom 10 Healthcare companies in South Korea by Net Cash Used Provided By Financing Activities are Samsung Biologics Co.,Ltd., Celltrion, Inc., Seegene, Inc., Hanmi Pharm. Co., Ltd., SK bioscience Co.,Ltd., Huons Global Co., Ltd., Ilsung Pharmaceuticals Co., Ltd., Chong Kun Dang Pharmaceutical Corp., JW Pharmaceutical Corporation and iNtRON Biotechnology, Inc..